Serum Desmosine Is Associated with Long-Term All-Cause and Cardiovascular Mortality in Bronchiectasis
- 15 September 2020
- journal article
- letter
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 202 (6), 897-899
- https://doi.org/10.1164/rccm.202002-0434LE
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbationEuropean Respiratory Journal, 2019
- Cardiovascular Outcomes after a Respiratory Tract Infection among Adults with Non–Cystic Fibrosis Bronchiectasis: A General Population–based StudyAnnals of the American Thoracic Society, 2018
- Correlates and assessment of excess cardiovascular risk in bronchiectasisEuropean Respiratory Journal, 2017
- Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in BronchiectasisAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Age-dependent elastin degradation is enhanced in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2016
- Bronchiectasis and the risk of cardiovascular disease: a population-based studyThorax, 2016
- Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research CollaborationEuropean Respiratory Journal, 2016
- Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPDEuropean Respiratory Journal, 2016
- The Bronchiectasis Severity Index. An International Derivation and Validation StudyAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Characterization and Validation of an Isotope-Dilution LC–MS/MS Method for Quantification of Total Desmosine and Isodesmosine in Plasma and SerumBioanalysis, 2013